APLN and coronary artery disorder: Utilizing advanced computational methods such as AlphaFold 3 for 3D structure prediction and HawDock 2.0 for molecular docking simulations, the findings reveal Apelin’s exceptional binding affinities and stability, making it a promising candidate for CAD therapy.